Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-1.44 Insider Own0.10% Shs Outstand146.63M Perf Week-5.18%
Market Cap2.63B Forward P/E- EPS next Y-1.75 Insider Trans- Shs Float101.14M Perf Month-4.93%
Income-179.70M PEG- EPS next Q-0.56 Inst Own86.70% Short Float15.88% Perf Quarter30.31%
Sales207.80M P/S12.65 EPS this Y23.20% Inst Trans2.16% Short Ratio5.24 Perf Half Y16.81%
Book/sh1.79 P/B10.02 EPS next Y12.50% ROA-75.50% Target Price32.20 Perf Year-38.55%
Cash/sh1.46 P/C12.28 EPS next 5Y13.60% ROE-88.20% 52W Range12.77 - 32.99 Perf YTD-40.45%
Dividend- P/FCF- EPS past 5Y-36.60% ROI-67.00% 52W High-45.56% Beta3.32
Dividend %- Quick Ratio6.00 Sales past 5Y91.10% Gross Margin94.20% 52W Low40.64% ATR1.41
Employees410 Current Ratio6.10 Sales Q/Q63.80% Oper. Margin- RSI (14)43.18 Volatility5.87% 7.06%
OptionableYes Debt/Eq0.00 EPS Q/Q6.70% Profit Margin- Rel Volume0.33 Prev Close17.93
ShortableYes LT Debt/Eq0.00 EarningsNov 06 AMC Payout- Avg Volume3.07M Price17.96
Recom2.20 SMA20-4.19% SMA50-10.85% SMA200-2.71% Volume438,119 Change0.17%
Dec-10-18Initiated Canaccord Genuity Hold $23
Sep-21-18Upgrade Piper Jaffray Neutral → Overweight
Aug-09-18Reiterated Stifel Hold $17 → $14
Aug-07-18Initiated Stifel Hold $17
Aug-06-18Downgrade Piper Jaffray Overweight → Neutral
Oct-06-17Resumed Goldman Neutral
Nov-11-16Initiated Goldman Neutral
Nov-08-16Upgrade BofA/Merrill Neutral → Buy
Oct-19-16Resumed ROTH Capital Neutral
Oct-04-16Initiated Leerink Partners Mkt Perform $34
Jun-22-16Downgrade BofA/Merrill Buy → Neutral
May-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Mar-30-16Reiterated Piper Jaffray Overweight $39 → $44
Feb-08-16Initiated BofA/Merrill Buy $40
Jan-22-16Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Dec-13-18 10:46AM  Why ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Could Be Your Next Investment Simply Wall St.
Dec-03-18 08:10AM  Analysis: Positioning to Benefit within Symantec, ACADIA Pharmaceuticals, Novavax, BBX Capital, Paychex, and US Foods Holding Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +6.51%
Nov-30-18 04:05PM  ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire -5.32%
Nov-28-18 11:01AM  Here's Why Acadia Pharmaceuticals Is Soaring Motley Fool +20.76%
07:00AM  Todays Research Reports on Stocks to Watch: Loxo Oncology and ACADIA Pharmaceuticals ACCESSWIRE
Nov-27-18 09:20PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock Business Wire -12.64%
03:22PM  Why Acadia Pharmaceuticals Is Plummeting Motley Fool
07:32AM  The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial Benzinga
06:55AM  Today's Research Reports on Trending Tickers: Novavax and ACADIA Pharmaceuticals ACCESSWIRE
Nov-26-18 04:08PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire +5.13%
Nov-12-18 03:26PM  Edited Transcript of ACAD earnings conference call or presentation 6-Nov-18 10:00pm GMT Thomson Reuters StreetEvents
01:55PM  Analysts Expect Breakeven For ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Simply Wall St.
Nov-06-18 06:30PM  Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:25PM  Acadia: 3Q Earnings Snapshot Associated Press
04:05PM  ACADIA Pharmaceuticals Reports Third Quarter 2018 Financial Results Business Wire
Nov-01-18 08:00AM  Todays Research Reports on Stocks to Watch: Tonix Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE +14.78%
Oct-31-18 06:30AM  ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial of Pimavanserin for Adjunctive Treatment in Patients with Major Depressive Disorder (MDD) Business Wire -7.63%
Oct-30-18 10:33AM  Earnings Preview: Acadia Pharmaceuticals (ACAD) Q3 Earnings Expected to Decline Zacks
08:00AM  The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio Benzinga
Oct-29-18 04:35PM  ACADIA Pharmaceuticals Announces Executive Leadership Change Business Wire
Oct-26-18 08:00AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Array BioPharma ACCESSWIRE
Oct-24-18 08:50AM  Market Trends Toward New Normal in UROGEN PHARMA, Cimarex Energy, Boingo Wireless, TransCanada, EXTRACTION O&G, and ACADIA Pharmaceuticals Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -12.55%
Oct-23-18 09:00AM  ACADIA Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 6, 2018 Business Wire
Oct-22-18 06:00AM  3 Biotech Stocks Poised to Rise by 15% or More Investopedia
Oct-12-18 08:00AM  Today's Research Reports on Trending Tickers: Oragenics and ACADIA Pharmaceuticals ACCESSWIRE
Oct-10-18 01:30PM  Here's Why ACADIA Pharmaceuticals Jumped 46% in September Motley Fool
10:35AM  Biotech Gearing Up for a Pullback? Investopedia
Sep-27-18 06:00AM  3 Biotechs Poised for 10% Gains Investopedia
Sep-26-18 03:07PM  ACADIA Pharmaceuticals Inc (NASDAQ:ACAD): Financial Strength Analysis Simply Wall St.
09:00AM  ACADIA Pharmaceuticals Announces Executive Appointments to Lead Medical Affairs and Science Business Wire
08:26AM  Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars Zacks
08:00AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Array BioPharma ACCESSWIRE
Sep-25-18 09:00AM  ACADIA Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference on October 2, 2018 Business Wire +7.86%
Sep-24-18 04:27PM  8 Stocks Poised to Change Direction TheStreet.com
08:00AM  Today's Research Reports on Trending Tickers: Geron and ACADIA Pharmaceuticals ACCESSWIRE
Sep-22-18 07:17AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Sep-21-18 06:12PM  FDA Confirms Positive Safety Profile of Acadia's Nuplazid Zacks +5.55%
03:53PM  Bulls bet on this pharma name. Plus, the trade on Zions CNBC Videos
11:21AM  Acadia's FDA Boost Is Just The Beginning, Piper Jaffray Says In Upgrade Benzinga
10:00AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) & Lead Plaintiff Deadline - September 17, 2018 GlobeNewswire
08:00AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and BioLineRx ACCESSWIRE
Sep-20-18 05:15PM  FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of NUPLAZID® (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinsons Disease Psychosis Business Wire +26.56%
05:01PM  Here's Why Acadia Pharmaceuticals Inc. Spiked Over 26% Today Motley Fool
01:16PM  Acadia stock spikes 19% after FDA finds drug has no additional safety problems MarketWatch
Sep-17-18 02:10PM  FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:00AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, FIZZ, RMTI, TTPH and FB GlobeNewswire
Sep-16-18 10:50PM  ACADIA PHARMACEUTICALS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD Business Wire
06:02PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD ACCESSWIRE
10:00AM  CLASS ACTION UPDATE -- DEADLINE MONDAY for ACAD and FIZZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Sep-15-18 03:00PM  FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Sep-14-18 10:50PM  ACADIA PHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD Business Wire
07:27PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline ACAD GlobeNewswire
12:50PM  IMPORTANT DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:45PM  SHAREHOLDER ALERT: PM QRTEA LOGM NLSN ACAD RMTI TTPH FB GDS SKX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Sep-13-18 06:57PM  Investors: The Law Offices of Howard G. Smith Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. (ACAD) GlobeNewswire
06:48PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Beverage, ACADIA, and Vuzix and Encourages Investors to Contact the Firm GlobeNewswire
04:28PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LCI, ACAD and FB GlobeNewswire
03:11PM  KESSLER TOPAZ MELTZER & CHECK, LLP:  Final Deadline Reminder for ACADIA PHARMACEUTICALS INC. Investors ACAD GlobeNewswire
12:39PM  MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Sep-12-18 07:21PM  Investors: The Law Offices of Howard G. Smith Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. (ACAD) Business Wire
05:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD ACCESSWIRE
02:49PM  CLASS ACTION UPDATE for ACAD and FB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:05PM  5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:25AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) & Lead Plaintiff Deadline - September 17, 2018 ACCESSWIRE
Sep-11-18 07:44PM  FINAL DEADLINE ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:10PM  IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Sep-10-18 09:00AM  Analyses of Pimavanserin Studies Evaluating Treatment in Alzheimers Disease Psychosis and Parkinsons Disease Psychosis Published in The Journal of Prevention of Alzheimers Disease Suggest Potential for Treating Dementia-Related Psychosis Business Wire
Sep-09-18 11:30AM  SHAREHOLDER ALERT: PDD AMPE NVRO PZZA ZN SBGI ACAD FIZZ TTPH FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Sep-08-18 12:32PM  INVESTOR ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Sep-07-18 07:09PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline ACAD GlobeNewswire
02:37PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, ABBV and FB GlobeNewswire
12:00PM  September 17th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. GlobeNewswire
Sep-06-18 12:05PM  CLASS ACTION UPDATE for GLCNF GLNCY, ACAD and FPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:27AM  Kessler Topaz Meltzer & Check, LLP Announces Important Deadline Reminder in Securities Fraud Class Action Lawsuit Filed Against ACADIA Pharmaceuticals Inc. ACCESSWIRE
Sep-05-18 06:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD ACCESSWIRE
12:37PM  SHAREHOLDER ALERT: TSLA LOGM GLCNF ACAD MD FPI RMTI ABBV GDS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:54AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) and Lead Plaintiff Deadline - September 17, 2018 ACCESSWIRE
Sep-04-18 09:50PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:15PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Pharmaceuticals, Inc. To Contact The Firm ACCESSWIRE
05:08PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, RMTI, ORCL, AMPE and CBS GlobeNewswire
05:05PM  Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline GlobeNewswire
03:15PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD ACCESSWIRE
01:00PM  CLASS ACTION UPDATE for FPI and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:00AM  ACADIA Pharmaceuticals to Present at the Morgan Stanley 16th Annual Global Healthcare Conference on September 13, 2018 Business Wire
Sep-02-18 10:00AM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of ACADIA Pharmaceuticals Inc. Investors (ACAD) GlobeNewswire
12:00AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, ACAD, RMTI and ABBV GlobeNewswire
Sep-01-18 08:20AM  ACAD NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc.; Important Sept. 17 Deadline - ACAD PR Newswire
Aug-31-18 10:50PM  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD GlobeNewswire
08:24PM  Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of ACADIA Pharmaceuticals Inc. Investors GlobeNewswire
05:04PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline ACAD GlobeNewswire
10:47AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, MD, FPI and ACAD GlobeNewswire
08:25AM  New Research Coverage Highlights Argos Therapeutics, Triumph Group, Rigel Pharmaceuticals, Egalet, Hertz Global, and ACADIA Pharmaceuticals Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Aug-30-18 07:10PM  September 17th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. Business Wire
05:06PM  SHAREHOLDER ALERT: GLNCY GLCNF ACAD GDS NLSN LOGM PDD NVRO LCI CBS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
03:30PM  IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:54PM  SHAREHOLDER ALERT: MRCY MD FPI ACAD TTPH FB ZN SBGI ORCL TSLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
12:00PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD ACCESSWIRE
Aug-29-18 05:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD PR Newswire
01:12PM  CLASS ACTION UPDATE for ACAD and TTPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:39AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) and Lead Plaintiff Deadline: September 17, 2018 ACCESSWIRE
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAKER BROS. ADVISORS LPDirectorNov 30Buy17.0011,764,705199,999,98535,976,940Dec 04 05:00 PM
BAKER BROS. ADVISORS LPDirectorSep 20Buy18.701,210,77622,646,98924,798,117Sep 24 08:32 AM
SOLAND DANIEL BDirectorMar 02Buy22.523,00067,56010,000Mar 02 06:09 PM
SOLAND DANIEL BDirectorMar 01Buy23.917,000167,3507,000Mar 02 06:09 PM
Baity GlennEVP AND GCJan 29Sale32.3936,5581,184,05583,734Jan 31 05:56 PM
Baity GlennEVP AND GCJan 10Option Exercise2.1850,179109,390120,292Jan 11 04:38 PM
Brege LauraDirectorJan 02Option Exercise8.2325,000205,80025,000Jan 04 06:23 PM
Baity GlennEVP AND GCJan 02Option Exercise2.1874,321162,020144,434Jan 04 06:24 PM
Brege LauraDirectorJan 02Sale30.0625,000751,5430Jan 04 06:23 PM
Baity GlennEVP AND GCJan 02Sale30.1474,3212,240,13970,113Jan 04 06:24 PM
open in yahoo | open in reuters | open in google